Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Underuse of Mohs Micrographic Surgery for the Treatment of Dermatofibrosarcoma Protuberans

Underuse of Mohs Micrographic Surgery for the Treatment of Dermatofibrosarcoma Protuberans PRACTICE GAPS Underuse of Mohs Micrographic Surgery for the Treatment of Dermatofibrosarcoma Protuberans ermatofibrosarcoma protuberans (DFSP) is a Foroozan et al resulted in complete excision of most tu- slow-growing, locally aggressive, spindle cell tu- mors treated with this modality. This demonstrates the D mor. The aim of surgical therapy for DFSP is tissue-sparing benefits of MMS compared with the wider complete tumor resection, resulting in clear margins. margins recommended for WLE. However, DFSP is associated with high recurrence rates, Possible solutions to narrow the practice gaps would particularly for larger tumors and for those occurring on be to educate dermatologists that meticulous evaluation the head and neck. of all peripheral and deep margins is the mainstay of DFSP The article by Foroozan et al in this issue of the treatment. Mohs surgeons who do not use immuno- Archives systematically reviewed and assessed the qual- stains as part of their surgical management of DFSP should ity of the published evidence on the recurrence rates of be taught how to do so, and provision should be made treatment with Mohs micrographic surgery (MMS) com- to facilitate the use of immunostaining as part of the MMS pared with wide local excision (WLE). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Dermatology American Medical Association

Underuse of Mohs Micrographic Surgery for the Treatment of Dermatofibrosarcoma Protuberans

Zwald, Fiona O.
JAMA Dermatology , Volume 148 (9) – Sep 1, 2012
Download PDF
1 page

Underuse of Mohs Micrographic Surgery for the Treatment of Dermatofibrosarcoma Protuberans

Abstract

PRACTICE GAPS Underuse of Mohs Micrographic Surgery for the Treatment of Dermatofibrosarcoma Protuberans ermatofibrosarcoma protuberans (DFSP) is a Foroozan et al resulted in complete excision of most tu- slow-growing, locally aggressive, spindle cell tu- mors treated with this modality. This demonstrates the D mor. The aim of surgical therapy for DFSP is tissue-sparing benefits of MMS compared with the wider complete tumor resection, resulting in clear margins. margins recommended for WLE....
Loading next page...
 
/lp/american-medical-association/underuse-of-mohs-micrographic-surgery-for-the-treatment-of-cgQF2QU5ni

References (2)

Publisher
American Medical Association
Copyright
Copyright 2012 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6068
eISSN
2168-6084
DOI
10.1001/archdermatol.2012.2685
pmid
22986860
Publisher site
See Article on Publisher Site

Abstract

PRACTICE GAPS Underuse of Mohs Micrographic Surgery for the Treatment of Dermatofibrosarcoma Protuberans ermatofibrosarcoma protuberans (DFSP) is a Foroozan et al resulted in complete excision of most tu- slow-growing, locally aggressive, spindle cell tu- mors treated with this modality. This demonstrates the D mor. The aim of surgical therapy for DFSP is tissue-sparing benefits of MMS compared with the wider complete tumor resection, resulting in clear margins. margins recommended for WLE. However, DFSP is associated with high recurrence rates, Possible solutions to narrow the practice gaps would particularly for larger tumors and for those occurring on be to educate dermatologists that meticulous evaluation the head and neck. of all peripheral and deep margins is the mainstay of DFSP The article by Foroozan et al in this issue of the treatment. Mohs surgeons who do not use immuno- Archives systematically reviewed and assessed the qual- stains as part of their surgical management of DFSP should ity of the published evidence on the recurrence rates of be taught how to do so, and provision should be made treatment with Mohs micrographic surgery (MMS) com- to facilitate the use of immunostaining as part of the MMS pared with wide local excision (WLE).

Journal

JAMA Dermatology – American Medical Association

Published: Sep 1, 2012

There are no references for this article.